---
title: Long-term use of everolimus for refractory arrhythmia in a child with tuberous
  sclerosis complex
date: '2023-12-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38130096/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231222170724&v=2.18.0
source: heidelberg[Affiliation]
description: Tuberous sclerosis complex is associated with the occurrence of cardiac
  rhabdomyomas that may result in life-threatening arrhythmia unresponsive to standard
  antiarrhythmic therapy. We report the case of an infant with multiple cardiac rhabdomyomas
  who developed severe refractory supraventricular tachycardia (SVT) that was successfully
  treated with everolimus. Pharmacological mTOR inhibition rapidly improved arrhythmia
  within few weeks after treatment initiation and correlated with a reduction ...
disable_comments: true
---
Tuberous sclerosis complex is associated with the occurrence of cardiac rhabdomyomas that may result in life-threatening arrhythmia unresponsive to standard antiarrhythmic therapy. We report the case of an infant with multiple cardiac rhabdomyomas who developed severe refractory supraventricular tachycardia (SVT) that was successfully treated with everolimus. Pharmacological mTOR inhibition rapidly improved arrhythmia within few weeks after treatment initiation and correlated with a reduction ...